Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia

NCT00386334 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.

NCT NCT00386334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00386334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly Subjects With Primary Chronic Insomnia
Lead sponsor
Sumitomo Pharma America, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
February 29, 2008
Enrollment
388 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia